Blumika 250mg Injection
Marketer
Blue Cross Laboratories Ltd
Salt Composition
Amikacin (250mg)
Overview Blumika 250mg Injection
Cefixime 250mg Injection combats bacterial infections, encompassing urinary tract, bone, joint, lung (pneumonia), brain, and bloodstream infections. Prophylactic use in hospitalized patients is also indicated. Its mechanism involves inhibiting bacterial proliferation. Administered intravenously (drip) or intramuscularly by a healthcare professional only, it necessitates regular, evenly spaced doses as prescribed. Complete the entire course, even with symptom improvement, to prevent relapse. Common side effects, such as injection site reactions and elevated blood urea, warrant consultation if persistent or if the infection remains. High doses may rarely cause vertigo, nephrotoxicity, and hearing impairment; hence, adherence to the doctor's instructions is crucial, including regular kidney, hearing, and urine tests. Pregnancy is a contraindication; inform your doctor about pregnancy, pregnancy planning, or breastfeeding.
Primary Ingredients of Blumika 250mg Injection
No information provided. Please provide the text you wish me to rewrite.
Uses of Blumika 250mg Injection
Infections caused by bacteria
Major Benefits of Blumika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Blumika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Blumika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Blumika 250mg Injection works:
The antibiotic injection, Blumika 250mg, inhibits bacterial proliferation by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Blumika 250mg Injection can be used concomitantly with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Blumika 250mg Injection to pregnant individuals poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in dire circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
Administration of Blumika 250mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
The injection Blumika 250mg can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is inadvisable while experiencing these effects.
KidneyCAUTION
For individuals with impaired kidney function, administering Blumika 250mg Injection requires careful consideration. A modified dosage of Blumika 250mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Blumika 250mg Injection in patients with liver impairment is likely safe. Current evidence indicates that dosage modification may be unnecessary for this patient group. However, physician consultation is recommended.
What if you forget to take Blumika 250mg Injection :
Omit a Blumika 250mg Injection dose? Seek medical advice.
Facts to Know About Blumika 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Aminoglycoside antibiotics |
3,018 People bought this recently